Skip to main content
. 2022 May 29;14(1):2078466. doi: 10.1080/19420862.2022.2078466

Figure 2.

Figure 2.

Endoglycosidase trimming of various antibody glycoforms to core GlcNAc attached to Asn297. Potential substitution of the core GlcNAc with a (1⟶6)-α-fucosyl moiety [▼] does not affect the endoglycosidase efficiency.

Monoclonal antibodies are glycosylated in the CH2 domain with a glycan that can take different forms, such a complex, hybrid or high-mannose. Each glycosylation profile can be trimmed down to the core GlcNAc with a specific endoglycosidase.